A Phase 2a Pharmacodynamic Study of TAK-448 in Participants With Hypogonadotropic Hypogonadism

Clinical trial NCT02369796 · TERMINATED

Trial details

NCT number: NCT02369796
Sponsor: Takeda
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Hypogonadotropic Hypogonadism

Start date: 2015-02-01
Primary completion: 2015-10-01
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.